Two CTCL Trails on Partial Hold After Patient Death
source: shutterstock.com

Two CTCL Trails on Partial Hold After Patient Death

  The two trials evaluating lacutamab, an investigational therapy developed to treat T-cell lymphomas, were put on partial hold by the FDA. The patient died of hemophagocytic lymphohistiocytosis, which is…

Continue Reading Two CTCL Trails on Partial Hold After Patient Death